Diagnosis and management of cardiac implantable electronic device infections (CIEDIs) are challenging and require a multidisciplinary team effort. This review uses a common clinical case presentation encountered in daily practice to demonstrate the complex approach to CIEDIs from various aspects.

2024年7月12日 · This guidance document provides recommendations to clinicians for treatment of infections caused by extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and difficult-to-treat Pseudomonas aeruginosa (DTR-P. aeruginosa).

2024年8月7日 · Approaches to empiric treatment, transitioning to oral therapy, duration of therapy, and other management considerations are discussed briefly. Suggested approaches apply for both adult and pediatric populations, although suggested antibiotic dosages are provided only for adults. Conclusions: The field of AMR is highly dynamic.

2024年10月15日 · Statistically significant reductions in the development of new gram-negative resistance were associated with BL de-escalation compared to no-change (hazards ratio (HR) 0.59 [95% CI: .48-.73]).

2023年7月18日 · In the present document, guidance is provided on the treatment of infections caused by extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E), AmpC β …

2023年7月18日 · Conclusions: The field of antimicrobial resistance is highly dynamic. Consultation with an infectious diseases specialist is recommended for the treatment of antimicrobial resistant infections. This document is current as of December 31, 2022 and will be updated periodically.

Among gram-negative species, Clinical and Laboratory Standards Institute (CLSI) breakpoints are only available for E. coli for fos-fomycin. Fosfomycin is not suggested for the treatment of infec …

2024年9月20日 · The Infectious Diseases Society of America (IDSA) has issued updated guidance on the treatment of antimicrobial-resistant (AMR) gram-negative infections. The 2024 …

†Definition: Uncomplicated gram-negative bloodstream infections are defined as the following (suggest all 4 conditions must be met): 22 Bloodstream infection confirmed to be secondary to …

2024年8月7日 · In the present document, guidance is provided on the treatment of infections caused by extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E), AmpC β …